Ventricular Assist Devices Market Report (2022 to 2030) –

Pune, Oct. 19, 2022 (GLOBE NEWSWIRE) — According to the latest report published by Growth Plus Reports, the global ventricular assist devices market is expected to clock US$ 2.52 billion by 2030 and to grow at a CAGR of 8.50% during the forecast period. The global ventricular assist devices market is driven by increasing heart failure cases, the growing geriatric population, and technological advancements. Additionally, favorable reimbursement policies and the introduction of novel products contribute to the growth of the global ventricular assist devices market. This exclusive information is published by Growth Plus Reports in its report titled “Ventricular Assist Devices Market – Global Outlook & Forecast 2022-2030”

Ventricular assist devices, also known as artificial circulatory support systems, aid in controlling blood flow and pumping blood from the heart’s left ventricle. Ventricular assist devices are implanted in the left ventricle or both ventricles during open heart surgery to maintain positive blood pressure throughout the body. Ventricular assist devices are divided into two types: continuous flow devices and pulsatile flow devices.

Download PDF Brochure of Ventricular Assist Devices Market Size – COVID-19 Impact and Global Analysis with Strategic Developments at: https://growthplusreports.com/inquiry/request-sample/ventricular-assist-device-market/7893

Growth Drivers

Increasing heart failure cases and the high prevalence of cardiovascular diseases are contributing to the growth of the global ventricular assist devices market. Cardiovascular diseases are the leading cause of death globally. According to the Centers for Disease Control and Prevention, approximately 697,000 Americans died from heart disease in 2020 In the United States. Between 2017 and 2018, the United States spent roughly US$ 229 billion on heart disease management. Coronary heart disease accounts for approximately two out of every ten deaths in the United States….